Alicia Henn's Biography

Alicia Henn, Chief Scientific Officer, BioSpherix, Ltd.

Alicia Henn is Chief Scientific Officer of BioSpherix, Ltd. She holds a PhD in Molecular Pharmacology and Cancer Therapeutics from Roswell Park Cancer Institute (2000). She also holds an MBA (2013) from University of Rochester, where she was a B cell biologist at the Center for Biodefense Immune Modeling. She is an inventor with patents from her work at RPCI, University of Rochester, and BioSpherix. Alicia writes the company blog, Cytocentric, and is also the founder/owner of the In Vitro Reproducibility Group on LinkedIn. Her research program focuses on physiologically relevant in vitro cell environments for reducing the time, money, and animals used to get novel therapeutics to the humans that need them.

The Total Quality Approach for Cytocentric Biofabrication

Thursday, 17 March 2016 at 16:30

Add to Calendar ▼2016-03-17 16:30:002016-03-17 17:30:00Europe/LondonThe Total Quality Approach for Cytocentric BiofabricationSELECTBIOenquiries@selectbiosciences.com

The ideal environment for a biofabrication apparatus is one that provides a full-time physical barrier between the apparatus and room air. The use of a barrier isolator to surround a bioprinter not only lowers biosafety risks for personnel, but also allows containment of a continuously sterile, controlled atmosphere for materials, cells, and the completed organ. We will actively discuss the many ways that a total quality approach to the biofabrication environment can bring reproducible control to production processes from materials preparation through organ manufacture to batch records.

Add to Calendar ▼2016-03-17 00:00:002016-03-18 00:00:00Europe/London3D-Printing in the Life Sciences, Biofabrication and Synthetic BiologySELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors